NovaQuest Pharma Opportunities Fund III, L.P. — Form D/A
NovaQuest Pharma Opportunities Fund III, L.P. of RALEIGH, NC, a pooled investment fund, filed a Form D amendment with the SEC on 2012-11-14. The offering totals $500.0M, of which $426.1M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2012-11-14
- Form: D/A
- Accession: 0001506260-12-000002
- Industry: Pooled Investment Fund
- Exemptions: 06, 3C, 3C.7
- Total offering: $500.0M
- Amount sold: $426.1M
- Remaining: $73.9M
- Investors: 8
- Date of first sale: 2010-11-12
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-150993
Issuer
- Name: NovaQuest Pharma Opportunities Fund III, L.P.
- CIK: 0001506260
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2010
- Address: 4208 SIX FORKS ROAD, RALEIGH, NC, 27609
- Phone: 919-459-8620
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| JOHN L BRADLEY | Director | RALEIGH, NC |
| Ernest Gerald Brown | Director | Raleigh, NC |
| Tadahiro Gerald Dantsuka | Director | Raleigh, NC |
| James Gerald O'Brien | Director | Raleigh, NC |
| Ronald J Wooten | Director | Raleigh, NC |
| N/A NQ HCIF General Partner, L.P. | Executive Officer | Raleigh, NC |
| N/A NQ HCIF GP, Ltd. | Executive Officer | Raleigh, NC |
| Ronald Gerald Wooten | Director | Raleigh, NC |
| Fred Gerald Cohen | Director | Raleigh, NC |
| Chris Gerald Gordon | Director | Raleigh, NC |
| Akito Gerald Umeda | Director | Raleigh, NC |
Other filings by this issuer (3)
More